Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMD
1376
DELISTED
Cantel Medical Corporation
CMD
| $23.9M | 0.01% |
540,533
+86,405
| +19% | +$3.22M |
|
1377
BridgeBio Pharma
BBIO
$16.2B
| $23.9M | 0.01% |
732,935
+10,198
| +1% | +$311K |
|
|
ALTR
1378
DELISTED
Altair Engineering Inc
ALTR
| $23.9M | 0.01% |
601,142
+32,291
| +6% | +$1.1M |
|
|
DRNA
1379
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $23.9M | 0.01% |
939,743
+107,414
| +13% | +$2.31M |
|
1380
Medifast
MED
$136M
| $23.9M | 0.01% |
171,925
+3,664
| +2% | +$336K |
|
1381
Compass Minerals
CMP
$1.08B
| $23.8M | 0.01% |
489,068
+16,126
| +3% | +$748K |
|
|
IBTX
1382
DELISTED
Independent Bank Group, Inc.
IBTX
| $23.8M | 0.01% |
588,096
+44,877
| +8% | +$1.45M |
|
1383
Hilton Grand Vacations
HGV
$3.61B
| $23.8M | 0.01% |
1,218,703
+265,029
| +28% | +$5.23M |
|
1384
Cal-Maine
CALM
$3.98B
| $23.8M | 0.01% |
535,259
+3,672
| +0.7% | +$156K |
|
1385
MillerKnoll
MLKN
$1.61B
| $23.8M | 0.01% |
1,008,157
+24,452
| +2% | +$552K |
|
|
EGOV
1386
DELISTED
NIC Inc
EGOV
| $23.8M | 0.01% |
1,035,766
-3,975
| -0.4% | -$94K |
|
1387
Horace Mann Educators
HMN
$2.19B
| $23.8M | 0.01% |
646,898
+3,975
| +0.6% | +$140K |
|
1388
Cabot Corp
CBT
$4.52B
| $23.7M | 0.01% |
639,568
-22,046
| -3% | -$738K |
|
1389
Trustmark
TRMK
$2.78B
| $23.7M | 0.01% |
964,738
-14,895
| -2% | -$359K |
|
|
NGHC
1390
DELISTED
National General Holdings Corp
NGHC
| $23.6M | 0.01% |
1,093,554
+21,230
| +2% | +$400K |
|
|
PGRE
1391
DELISTED
Paramount Group
PGRE
| $23.6M | 0.01% |
3,062,956
-50,387
| -2% | -$425K |
|
|
NAV
1392
DELISTED
Navistar International
NAV
| $23.6M | 0.01% |
835,165
+13,490
| +2% | +$320K |
|
1393
Central Garden & Pet Co Class A
CENTA
$2.54B
| $23.5M | 0.01% |
870,611
-26,709
| -3% | -$670K |
|
|
OPI
1394
DELISTED
Office Properties Income Trust
OPI
| $23.5M | 0.01% |
904,247
+3,585
| +0.4% | +$93.3K |
|
1395
Yext
YEXT
$558M
| $23.4M | 0.01% |
1,411,560
+92,175
| +7% | +$1.29M |
|
1396
Reynolds Consumer Products
REYN
$5.54B
| $23.4M | 0.01% |
673,754
+380,805
| +130% | +$12.4M |
|
1397
Upbound Group
UPBD
$1.14B
| $23.3M | 0.01% |
839,105
+3,666
| +0.4% | +$81.5K |
|
|
CALY
1398
Callaway Golf Company
CALY
$3.1B
| $23.3M | 0.01% |
1,332,963
+13,940
| +1% | +$194K |
|
|
BIG
1399
DELISTED
Big Lots, Inc.
BIG
| $23.3M | 0.01% |
555,563
+11,596
| +2% | +$329K |
|
1400
GDS Holdings
GDS
$6.38B
| $23.3M | 0.01% |
294,105
+63,549
| +28% | +$3.93M |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.